The article explores the origins of the legendary rivalry in Naruto, tracing it back to Hagoromo Otsutsuki's sons, Indra and Ashura. Indra, the elder, believed in power, while Ashura sought peace ...

We are also delighted to welcome Bob White to the Supervisory Board and are very pleased with the re-appointment of Indra Nooyi and Chua Sock Koong. With our highly knowledgeable and experienced ...

Indra Nooyi has ended her association with the International Cricket Council (ICC). The former CEO of PepsiCo, who was the first-ever independent woman director of the world body, no longer holds ...

We know that breakthrough infections, while uncommon, can spread the virus. But vaccinated people are less likely than unvaccinated people to infect those around them. One of the benefits of the ...

Former PepsiCO CEO Indra Nooyi, whose leadership style exemplifies qualities I strive to embody as CEO and in my board positions Businessperson Who Has Impressed You Most: I’ve observed ...

Jennifer Maloney is deputy corporate bureau chief and retail editor for The Wall Street Journal in New York. She helps oversee a team of reporters covering consumer brands, retail, manufacturing, ...

Vor Biopharma CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, based on currently available ...

Vor Bio is the latest cell therapy company to reach the end of the road. The biotech is immediately winding down clinical and manufacturing operations and laying off almost all staff. Around 95% ...

May 7 (Reuters) - Bio-Techne (TECH.O), opens new tab on Wednesday beat Wall Street estimates for third-quarter profit, driven by growth in its unit that provides proteins, antibodies and other ...

Cardinal Robert Francis Prevost was elected Pope Leo XIV on Thursday, May 8 — the first pope from the United States. Smiling and waving while wearing more traditional papal garb than his ...

The board of Vor Bio is exploring a potential sale, winding down operations and cutting the vast majority of its workforce. The clinical-stage cell-and-genome engineering company said Thursday ...